GO
Loading...

Amgen Inc

More

  • Bear Stearns' Amgen Call  Brings On More Gallows Humor Wednesday, 26 Mar 2008 | 1:16 PM ET

    This morning, Bear Stearns biotech analyst Mark Schoenebaum and a couple of members of his research team hosted a conference call with a 50-page PowerPoint about Amgen. The purpose was to drill down into the looming court decision over whether Roche will be able to launch a competing anemia drug in the U.S. for kidney dialysis patients.

  • Gilead Sciences "Pushes Out" Amgen As Number 2 Biotech Monday, 24 Mar 2008 | 12:40 PM ET

    Investors now think that a biotech company with less than one-third the revenue of Amgen is worth more than the former sector king. Elizabeth Trotta at TheStreet.com took note of this late last week but I thought it was worth pointing out.

  • Dow Drops 293... Stocks Fall 2% Wednesday, 19 Mar 2008 | 6:25 PM ET

    Plunging commodities combined with weakness in energy and basic materials dragged down the Dow as well as the broader stock market. What's the word on the Street?

  • Stocks on the Move: NYSE, GM, Amgen and More Tuesday, 18 Mar 2008 | 7:39 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of NYSE and GM popped while Amgen and Newmont Mining dropped.

  • Dow Gains 3.5% in Financial-Led Rally Tuesday, 18 Mar 2008 | 6:11 PM ET

    Stocks soared Tuesday, led by financials, as the market breathed a huge sigh of relief following better-than-expected earnings from Goldman Sachs and Lehman Brothers.

  • Amgen And Its Rather Anemic Stock Performance Tuesday, 18 Mar 2008 | 11:54 AM ET

    Shares of Amgen closed just above 43 bucks yesterday. That's more than a five-year low. And they're falling even lower in early trading this morning. Today the company is making its first investor presentation since last week's FDA advisory committee vote to restrict usage of Amgen's anemia drugs on cancer patients.

  • I am at the Genentech analyst meeting at the Mandarin Oriental Hotel next to the new Time Warner Center in Columbus Circle in Manhattan. The room is packed with an estimated 300-plus analysts, investors, reporters and Genentech execs.

  • Strong Rebound For Stocks Thursday, 13 Mar 2008 | 6:26 PM ET

    A 200+ point decline turns into a net gain on the Big Board as Standard & Poor's gives the market some confidence that the end is near. Also, oil and gold hit records and more in the Word on the Street.

  • Amgen, J&J Drug Benefits Upheld by FDA Panel Thursday, 13 Mar 2008 | 4:51 PM ET
    The sign outside Amgen Inc.'s entrance. Thousand Oaks, Calif.

    Scientists advising the Food and Drug Administration said anemia drugs sold by Amgen and Johnson & Johnson should be allowed to stay on the market for chemotherapy patients.

  • Stocks Close Higher After S&P-Fueled Rally Thursday, 13 Mar 2008 | 4:32 PM ET

    Stocks closed higher Thursday after Standard & Poor's delivered the words Wall Street was waiting to hear: The end is in sight.

  • Amgen, JNJ Get Somewhat Mixed Message From FDA Panel Thursday, 13 Mar 2008 | 4:32 PM ET

    Amgen, the world's biggest biotech company in terms of sales (Genentech dwarfs Amgen in market cap: $86 billion vs. $51 billion) and Dow component Johnson & Johnson avoided a worst-case scenario this afternoon.

  • 5-Star Picks: Net and Biotech Plays Thursday, 13 Mar 2008 | 11:41 AM ET

    Five-star fund managers are looking past this week's market gyrations and offering investors some promising stock opportunities.

  • Amgen's Anemia Drug Showdown Wednesday, 12 Mar 2008 | 4:26 PM ET

    Ahead of the big FDA Advisory Committee meeting tomorrow, Amgen held a quick conference call with some reporters this afternoon. The outside panel of experts will be deciding whether to recommend putting more restrictions on the use of the blockbuster drugs used to fight anemia in cancer patients getting chemo. For Johnson and Johnson and especially Amgen, the stakes are high.

  • Pops & Drops: U.S. Steel, Thornburg Mortgage... Tuesday, 11 Mar 2008 | 6:34 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of U.S. Steel and Thornburg Mortgage popped while UnitedHealth and Dick's Sporting Goods dropped.

  • Stocks Have Their Best Day in Five Years Tuesday, 11 Mar 2008 | 4:55 PM ET

    Stocks shot up Tuesday after a liquidity announcement from the Federal Reserve.

  • Amgen, Johnson & Johnson & The FDA Tuesday, 11 Mar 2008 | 1:23 PM ET

    Shares of biotech giant Amgen fell as low as $43.14 (a new bottom) this morning after the briefing documents for Thursday's Food and Drug Administration Advisory Committee meeting were posted on the agency's website.

  • Dow Jumps 2%, Led by Financials Tuesday, 11 Mar 2008 | 11:10 AM ET

    Stocks shot up Tuesday after a liquidity announcement from the Federal Reserve.

  • Big Week For Biotech Monday, 10 Mar 2008 | 6:46 PM ET

    This is a big week for the world's top-two biotechnology companies and their investors. What’s going on and how can you trade it?

  • One Giant Leap for MannKind Monday, 10 Mar 2008 | 5:11 PM ET

    Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.

  • Amgen And Genentech: A Big Biotech Double Play Monday, 10 Mar 2008 | 10:50 AM ET
    AMGEN

    This is a big week for the world's top-two biotechnology companies and their investors. Amgen goes before an FDA Advisory Committee Thursday about the side effects of its bread-and-butter franchise Aranesp.